Impact of Discontinuing Dornase Alfa in People With CF on Highly Effective CFTR Modulator Therapy-A SIMPLIFY Sub-Study
Clinical trial NCT06350474 · COMPLETED
Trial details
- NCT number
- NCT06350474
- Sponsor
- Nicole Hamblett
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-25
- Primary completion
- 2022-07-11
- Enrollment
- 477
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.